BWV

NASDAQ

Blue Water Biotech Inc.

SectorHealth CareIndustryBiotechnology: Pharmaceutical PreparationsIPO2022

$0.18-0.01 (-4.63%)

News25/Ratings0

Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The company was incorporated in 2018 and is based in Cincinnati, Ohio.

Latest news

25 items

799dINSIDER
SEC Form 3 filed by new insider Singh Ajit
3 - Onconetix, Inc. (0001782107) (Issuer)
799dINSIDER
SEC Form 3 filed by new insider Meier Thomas
3 - Onconetix, Inc. (0001782107) (Issuer)
801dSEC
SEC Form S-1 filed by Blue Water Biotech Inc.
S-1 - Onconetix, Inc. (0001782107) (Filer)
801dSEC
SEC Form PRE 14A filed by Blue Water Biotech Inc.
PRE 14A - Onconetix, Inc. (0001782107) (Filer)
802dSEC
Blue Water Biotech Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Onconetix, Inc. (0001782107) (Filer)
803dSEC
Blue Water Biotech Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
8-K - Onconetix, Inc. (0001782107) (Filer)
814dSEC
SEC Form S-8 filed by Blue Water Biotech Inc.
S-8 - Onconetix, Inc. (0001782107) (Filer)
817dSEC
Blue Water Biotech Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
8-K - Onconetix, Inc. (0001782107) (Filer)
820d13D/G
SEC Form SC 13G/A filed by Blue Water Biotech Inc. (Amendment)
SC 13G/A - Onconetix, Inc. (0001782107) (Subject)
827dSEC
Blue Water Biotech Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
8-K - Onconetix, Inc. (0001782107) (Filer)
834dSEC
Blue Water Biotech Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
8-K - Onconetix, Inc. (0001782107) (Filer)
843dINSIDER
New insider Schiess Ralph claimed ownership of 269,749 shares (SEC Form 3)
3 - Onconetix, Inc. (0001782107) (Issuer)
844d13D/G
SEC Form SC 13G/A filed by Blue Water Biotech Inc. (Amendment)
SC 13G/A - Onconetix, Inc. (0001782107) (Subject)
849dINSIDER
New insider Bruhlmann Christian claimed ownership of 236,029 shares (SEC Form 3)
3 - Onconetix, Inc. (0001782107) (Issuer)
849dSEC
Blue Water Biotech Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
8-K - Onconetix, Inc. (0001782107) (Filer)
850d13D/G
SEC Form SC 13G filed by Blue Water Biotech Inc.
SC 13G - Onconetix, Inc. (0001782107) (Subject)
850dSEC
Blue Water Biotech Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits (Amendment)
8-K/A - Onconetix, Inc. (0001782107) (Filer)
856dSEC
Blue Water Biotech Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
8-K - Onconetix, Inc. (0001782107) (Filer)
858dNEWS
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Aclarion (NASDAQ:ACON) shares increased by 59.9% to $0.47 during Tuesday's after-market session. The company's market cap stands at $4.4 million. Clene (NASDAQ:CLNN) stock rose 8.1% to $0.59. The market value of their outstanding shares is at $75.6 million. Acutus Medical (NASDAQ:AFIB) stock rose 6.83% to $0.21. The company's market cap stands at $6.1 million. Avinger (NASDAQ:AVGR) stock moved upwards by 5.55% to $2.85. The market value of their outstanding shares is at $3.6 million. Blue Water Biotech (NASDAQ:BWV) stock increased by 5.26% to $0.21. The company's market cap stands at $3.9 million. Biora Therapeutics (NASDAQ:BIOR) stock moved upwards by 5.11% to $1.23. The compa
858dNEWS
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Biomerica (NASDAQ:BMRA) shares rose 54.5% to $1.53 during Tuesday's pre-market session. The market value of their outstanding shares is at $25.7 million. Cingulate (NASDAQ:CING) stock increased by 33.33% to $2.84. The company's market cap stands at $2.6 million. Arcutis Biotherapeutics (NASDAQ:ARQT) stock increased by 31.14% to $3.2. The market value of their outstanding shares is at $302.0 million. Panbela Therapeutics (NASDAQ:PBLA) shares increased by 30.54% to $0.6. The market value of their outstanding shares is at $3.0 million. NRX Pharmaceuticals (NASDAQ:NRXP) shares rose 30.08% to $0.44. The company's market cap stands at $37.5 million. Alaunos Therapeutics (NASDAQ:TCRT)
858dSEC
Blue Water Biotech Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Onconetix, Inc. (0001782107) (Filer)
858dPR
Onconetix™ Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders
CINCINNATI, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Onconetix, Inc., (NASDAQ:BWV) ("Onconetix" or the "Company") today issued the following shareholder letter from the Company's Chief Executive Officer, Dr. Neil Campbell. To Our Valued Shareholders, As 2023 draws to a close, I am eager to share with you the significant strides Onconetix, Inc. (formerly Blue Water Biotech, Inc.) has made in our journey towards becoming a leader in oncology. This past quarter has been transformative, marked by strategic shifts and notable achievements, all aimed at enhancing the value we bring to you as our shareholders. To reflect our recent achievements and renewed oncology focus, we have rebranded as Onconet
859dSEC
Blue Water Biotech Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
8-K - Blue Water Biotech, Inc. (0001782107) (Filer)
859dNEWS
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Biomerica (NASDAQ:BMRA) shares rose 71.7% to $1.7 during Monday's pre-market session. The market value of their outstanding shares is at $28.5 million. Arcutis Biotherapeutics (NASDAQ:ARQT) shares rose 41.8% to $3.46. The market value of their outstanding shares is at $326.5 million. Alaunos Therapeutics (NASDAQ:TCRT) stock increased by 32.74% to $0.06. The company's market cap stands at $14.5 million. Akili (NASDAQ:AKLI) shares moved upwards by 29.46% to $0.54. The company's market cap stands at $42.2 million. Applied DNA Sciences (NASDAQ:APDN) stock moved upwards by 25.6% to $0.78. The company's market cap stands at $10.6 million. NRX Pharmaceuticals (NASDAQ:NRXP) shares rose
859dNEWS
Blue Water Biotech Acquires Proteomedix AG, A Private, Commercial-stage Diagnostics Oncology Company, In Stock Consideration; No Terms Disclosed
The acquisition of Proteomedix for all stock consideration provides its shareholders with an initial 19.9% ownership stake of Onconetix and introduced a new name for the combined Company: Onconetix, Inc. Two members of Proteomedix' leadership team will become executives of Onconetix.